Charming Medical Limited (MCTA)

NASDAQ: MCTA · Real-Time Price · USD

29.11

-0.25 (-0.83%)

Nov 11, 2025, 4:00 PM EDT - Market closed

Charming Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Cash & Equivalents	4.7	0.82	2.1	1.93
Short-Term Investments	1.84	1.94	-	-
Cash & Short-Term Investments	6.54	2.76	2.1	1.93
Cash Growth	136.71%	31.26%	9.04%	-
Accounts Receivable	0.2	0.4	0.35	0.19
Other Receivables	-	-	0.89	1.82
Total Trade Receivables	0.2	0.4	1.24	2
Inventory	0.03	0.03	0.03	0.07
Other Current Assets	1.41	0.18	0.3	0.12
Total Current Assets	8.17	3.37	3.67	4.12
Net Property, Plant & Equipment	1.33	1.21	0.92	1.8
Other Long-Term Assets	0.36	0.78	0.29	0.47
Total Assets	9.87	5.36	4.88	6.38

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Accrued Expenses	0.42	0.25	0.45	0.24
Short-Term Debt	0.19	0.31	0.44	0.59
Current Portion of Leases	0.37	0.49	0.37	0.74
Unearned Revenue	3.05	3.46	4.5	5.6
Other Current Liabilities	0.32	0.44	0.12	-
Total Current Liabilities	4.33	4.95	5.88	7.17
Long-Term Leases	0.36	0.36	0.15	0.48
Total Long-Term Liabilities	0.36	0.36	0.15	0.48
Total Liabilities	4.69	5.31	6.03	7.65

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Common Stock	0	0	0	0
Additional Paid-in Capital	5.1	-0.07	-0	-0
Accumulated Other Comprehensive Income	-0.01	-0	0	0
Retained Earnings	0.1	0.12	-1.08	-1.16
Total Common Shareholders' Equity	5.18	0.05	-1.08	-1.16
Minority Interest	-	-	-0.07	-0.11
Shareholders' Equity	5.18	0.05	-1.15	-1.27
Total Liabilities & Equity	9.87	5.36	4.88	6.38

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Total Debt	0.91	1.16	0.96	1.81
Net Cash (Debt)	5.63	1.6	1.14	0.12
Net Cash Growth	251.62%	40.13%	854.46%	-
Net Cash Per Share	0.35	0.10	-	-
Book Value	5.18	0.05	-1.08	-1.16
Book Value Per Share	0.32	0.00	-0.00	-0.00
Tangible Book Value	5.18	0.05	-1.08	-1.16
Tangible Book Value Per Share	0.32	0.00	-0.00	-0.00

SEC Filings: 10-K · 10-Q